CIK 0001196298 · Non-accelerated filer<br>Smaller reporting company
NEPHROS INC
Sign in to watch- Ticker
- NEPH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133971809
- Phone
- 201.343.5202
- Business address
- 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Spandow Oliver J. Director | Grant or award | +3,916 | 126,797 | ||
| 2026-11-09 | Amron Arthur H Director | Grant or award | +3,514 | 162,137 | ||
| 2026-09-14 | WEXFORD CAPITAL LP 10% owner | Other disposition | −3,355,111 | 189,377 | ||
| 2026-09-14 | WEXFORD CAPITAL LP 10% owner | Other disposition | −22,710 | $3.95 | $90K | 166,667 |
| 2026-09-14 | Amron Arthur H Director | Other acquisition | +17,749 | 158,623 | ||
| 2026-09-14 | Amron Arthur H Director | Other acquisition | +2,836 | 2,836 | ||
| 2026-09-14 | Amron Arthur H Director | Other acquisition | +22,710 | $3.95 | $90K | 25,546 |
| 2026-08-18 | WEXFORD CAPITAL LP 10% owner | Option exercise | +812 | $3.60 | $3K | 56,872 |
| 2026-08-18 | WEXFORD CAPITAL LP 10% owner | Option exercise · Stock Option (Right to Buy) | −3,765 | 36,198 | ||
| 2026-08-12 | Amron Arthur H Director | Grant or award | +2,418 | 140,874 | ||
| 2026-05-11 | Amron Arthur H Director | Grant or award | +3,574 | 138,456 | ||
| 2026-03-23 | Banks Robert R. Jr. President and CEO | Option exercise | +120,000 | $1.44 | $173K | 190,000 |
| 2026-03-23 | Banks Robert R. Jr. President and CEO | Option exercise · Stock Option (right to buy) | −120,000 | 237,165 | ||
| 2026-03-23 | Krandel Judy Chief Financial Officer | Option exercise | +68,861 | $1.71 | $118K | 68,861 |
| 2026-03-23 | Krandel Judy Chief Financial Officer | Option exercise · Stock Option (right to buy) | −68,861 | 53,663 | ||
| 2026-03-16 | Amron Arthur H Director | Grant or award | +3,610 | 134,882 | ||
| 2026-03-16 | Krandel Judy Chief Financial Officer | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2025-11-10 | Nettis Lisa Marie Director | Grant or award | +1,622 | 1,622 | ||
| 2025-11-10 | Spandow Oliver J. Director | Grant or award | +8,036 | 122,881 | ||
| 2025-11-10 | Amron Arthur H Director | Grant or award | +5,391 | 131,272 |
Page 1 of 8 · 158 trades